Angiozyme

From Wikipedia, the free encyclopedia

Angiozyme is a substance that is being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Also called RPI.4610.

[edit] External links

• Angiozyme entry in the public domain NCI Dictionary of Cancer Terms

This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms